PROGNOSIS
Mortality in people with dementia taking antipsychotics higher than in those taking other psychiatric medications
| The first 150 words of the full text of this article appear below. |
Dr Helen C Kales
Correspondence to: Dr Helen C Kales, MD, Department of Psychiatry, University of Michigan, Box 5765, 4250 Plymouth Road, Ann Arbor, MI 48109, USA; kales@umich.edu
Is there a difference in mortality rate in the year after starting a new antipsychotic for neuropsychiatric symptoms of dementia and other psychiatric drugs?
10 615 older adults (over 65 years old) diagnosed with dementia in fiscal years 2002 or 2003 who started outpatient psychiatric medication within 6 months of being diagnosed with dementia. Exclusions: using psychiatric medication in 6 months prior to dementia diagnosis; receiving lithium; having a seizure disorder.
National Department of Veterans Affairs (VA) data registries, USA; fiscal years 2001–5.
Type of psychiatric medication: antipsychotic (conventional, atypical, or both) or other. Analyses were adjusted for potential confounders, including: age, gender, use of cholinesterase inhibitors, delirium diagnosis present at time of first prescription filling, date of starting psychiatric medication, schizophrenia
St Charles Hospital, Central North West London Foundation NHS Trust, London, UK
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
